Scientific Advisory Board
Med Cell Bahamas is a world leader in isolation and banking of adipose derived adult stem cells. The Scientific Advisory Board of Med Cell Bahamas is made up of leaders of the medical-scientific environment of stem cell research. The Board ensures that the activities of the company are factually and technically correct and always on the cutting edge of medicine and science. Their task is to contribute to the quality of concrete research projects and thematic focus of the research at Med Cell Bahamas. Med Cell Bahamas is not involved in the research or storage of embryonic stem cells.
The company has performed preclinical evaluations such as:
The Company is currently working on the following R&D Projects:
The company has performed preclinical evaluations such as:
- In vitro studies on differentiation potential to cartilage, bone, adipocytes, muscle and nerve tissue
- Labelling of mesenchymal stem cells with SPIONs enabling studies on biodistribution and long term engraftment
- In vitro toxicological studies
The Company is currently working on the following R&D Projects:
- Insulin producing cells from ad-MSC (Diabetes type 1 and 2)
- Dopamine producing cells from ad-MSC (Parkinson disease)
- Dendritic cells (anti cancer and immunomodulation)
- Olfactory ensheathing cells (isolation, propagation, therapy of spinal cord injury)
- In vitro cartilage model (regeneration, anti apoptosis, anti inflammatory, drug testing) EXO-Cart-Trial
- Stem cells from oral mucous membrane
- Stem cell media
- Cardio-GOD-Trial
- Dermo-RAP-Trial
- RNA/EXO shuffle
- Photobiomodulation in age-related macular degeneration of the retina